Medicine meets mentorship.
GLP-1 receptor agonists like Semaglutide and Tirzepatide have changed the weight loss landscape. These medications work with your body's own biology — regulating appetite, slowing gastric emptying, and improving insulin sensitivity. The science is real, and the results speak for themselves.
But medication alone isn't a program. At LeMed Spa, every weight management patient receives physician oversight, regular check-ins, dose titration, nutritional guidance, and a plan designed to maintain results long after the initial treatment phase. This is medical weight loss with a concierge approach.
This Isn't a Quick Fix
We don't prescribe and disappear. Our weight management program is built on accountability, medical supervision, and a genuine investment in your long-term health. Every dose adjustment, every check-in, every nutritional conversation is designed to help you build habits that outlast the prescription.
Comprehensive care, real results.
Sustainable Weight Loss
GLP-1 medications enable significant, sustained weight reduction by working with your body's natural appetite and satiety hormones — not against them.
Appetite Regulation
Semaglutide and Tirzepatide reduce cravings and food noise by acting on the same brain receptors that control hunger and fullness signaling.
Metabolic Health
Beyond weight loss — GLP-1 medications improve insulin sensitivity, reduce inflammation, and support cardiovascular health markers.
Body Composition
Combined with nutritional guidance and optional IV therapy support, our program helps preserve lean muscle mass while targeting fat loss.
Nutritional Guidance
Personalized nutritional counseling that works alongside your medication. Practical strategies for protein intake, meal planning, and mindful eating.
Ongoing Support
Regular check-ins, dose adjustments, lab monitoring, and a clinical team that knows your name. This is concierge weight management.
Landmark science. Real-world results.
Semaglutide and Tirzepatide are FDA-approved for chronic weight management, backed by the largest obesity pharmacotherapy trials ever conducted. The STEP program (Semaglutide, NEJM 2021, n=1,961) and SURMOUNT program (Tirzepatide, NEJM 2022, n=2,539) demonstrated sustained, clinically significant weight loss with manageable side effect profiles.
Program Details
Everything you need to know before starting your weight management journey.
Your health, your terms.
Book a consultation to see if medical weight management is right for you. Our physician will review your health history, discuss your goals, and design a personalized program.